Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-16 Purchase | 2024-09-18 11:40 am | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 20,000 | $0.04 | $800 | 4,606,626 (Direct) | View |
| 2024-02-26 Purchase | 2024-02-29 6:11 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Co-President & COO | 115,200 | $0.12755 | $14,694 | 795,718 (Indirect Direct) | View |
| 2023-08-25 Purchase(A) | 2024-01-03 4:59 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 121,000 | $0.12632 | $15,285 | 680,518 (Indirect Direct) | View |
| 2023-12-20 Sale | 2023-12-21 11:34 am | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 32,500 | $0.05 | $1,625 | 4,586,626 (Direct) | View |
| 2022-10-09 Purchase | 2023-12-19 7:44 pm | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 139,200 | $0.2221 | $30,916 | 9,066,552 (Direct) | View |
| 2023-12-15 Sale | 2023-12-19 7:44 pm | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 6,000 | $0.11 | $660 | 9,066,552 (Direct) | View |
| 2023-08-25 Purchase | 2023-12-04 8:33 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 15,609 | $0.1296 | $2,023 | 680,518 (Indirect Direct) | View |
| 2022-09-20 Purchase | 2023-06-02 1:23 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 29,450 | $0.28975 | $8,533 | 559,518 (Indirect Direct) | View |
| 2022-11-03 Purchase | 2022-12-01 1:35 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 52,600 | $0.40352 | $21,225 | 12,196,651 (Indirect Direct) | View |
| 2022-10-31 Purchase | 2022-11-03 2:50 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 27,500 | $0.43545 | $11,975 | 12,144,051 (Indirect Direct) | View |
| 2022-10-24 Purchase | 2022-10-31 2:59 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 69,400 | $0.27793 | $19,288 | 12,116,551 (Indirect Direct) | View |
| 2022-10-19 Purchase | 2022-10-24 6:34 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 65,000 | $0.17385 | $11,300 | 12,047,151 (Indirect Direct) | View |
| 2022-10-17 Purchase | 2022-10-19 2:21 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 45,000 | $0.19333 | $8,700 | 11,982,151 (Indirect Direct) | View |
| 2022-10-13 Purchase | 2022-10-17 1:01 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 97,500 | $0.17641 | $17,200 | 11,937,151 (Indirect Direct) | View |
| 2022-10-11 Purchase | 2022-10-13 4:05 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 165,000 | $0.0803 | $13,250 | 11,839,651 (Indirect Direct) | View |
| 2022-09-26 Purchase | 2022-10-12 1:04 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 185,000 | $0.11011 | $20,370 | 11,674,651 (Indirect Direct) | View |
| 2022-07-19 Purchase | 2022-07-25 12:49 pm | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 3,200 | $0.39 | $1,248 | 530,068 (Indirect Direct) | View |
| 2022-05-27 Purchase | 2022-06-03 11:52 am | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Director & COO | 5,000 | $0.385 | $1,925 | 526,868 (Indirect Direct) | View |
| 2022-05-20 Purchase | 2022-06-02 7:49 pm | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 7,000 | $0.49286 | $3,450 | 11,489,651 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 4:40 pm | N/A 2034-01-31 | Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director | 100,000 | $0.15 | 100,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:39 pm | N/A 2034-01-31 | Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director | 100,000 | $0.15 | 100,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:38 pm | N/A 2034-01-31 | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 100,000 | $0.15 | 100,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:37 pm | 2024-02-01 2034-01-31 | Emmaus Life Sciences Inc. | EMMA | Stark Charles William CSO & EVP Clinical Development | 200,000 | $0.15 | 200,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:35 pm | 2024-02-01 2034-01-31 | Emmaus Life Sciences Inc. | EMMA | Sekulich George Co-President & CCO | 200,000 | $0.15 | 200,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:34 pm | 2024-02-01 2034-01-31 | Emmaus Life Sciences Inc. | EMMA | NAGASAKI YASUSHI CFO | 200,000 | $0.15 | 200,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:32 pm | 2024-02-01 2034-01-31 | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C Co-President & COO | 200,000 | $0.15 | 200,000 (Direct) | View |
Ownership(A) | 2023-12-20 10:33 am | N/A N/A | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 0 | $0 | 278,500 (Direct) | View |
| 2023-12-15 Other | 2023-12-19 7:44 pm | N/A N/A | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 240,000 | $0 | 9,066,552 (Direct) | View |
| 2023-12-15 Other | 2023-12-19 7:44 pm | N/A N/A | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 4,447,426 | $0.29 | 9,066,552 (Direct) | View |
| 2023-12-15 Other | 2023-12-19 7:40 pm | N/A N/A | Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director | 3,760,983 | $0.29 | 9,800,014 (Direct) | View |
| 2023-01-18 Other | 2023-12-19 7:40 pm | N/A N/A | Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director | 2,000,000 | $0.5 | 9,800,014 (Direct) | View |
| 2023-01-12 Option Award(A) | 2023-01-19 5:54 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 500,000 | $4.5 | 500,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 2:36 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director | 100,000 | $4.5 | 100,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 2:35 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | ZEN Wei Peu Director | 100,000 | $4.5 | 100,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 2:34 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 100,000 | $4.5 | 100,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 2:32 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Stark Charles William SVP, Clinical Development | 100,000 | $4.5 | 100,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 2:31 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | Sekulich George CIO & SVP | 100,000 | $4.5 | 100,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 2:29 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | NAGASAKI YASUSHI CFO | 150,000 | $4.5 | 150,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 2:27 pm | N/A 2033-01-11 | Emmaus Life Sciences Inc. | EMMA | LEE WILLIS C COO | 750,000 | $4.5 | 750,000 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 1:59 pm | 2023-01-12 2028-01-11 | Emmaus Life Sciences Inc. | EMMA | Niihara Yutaka Chairman and CEO 10% Owner | 7,500,000 | $4.5 | 0 (Direct) | View |
Ownership | 2022-10-06 1:05 pm | 2016-01-14 2026-01-14 | Emmaus Life Sciences Inc. | EMMA | Zwicker Ian Harvey Director | 0 | $0 | 220,529 (Direct) | View |
Ownership | 2022-10-06 1:03 pm | 2022-09-16 2025-09-16 | Emmaus Life Sciences Inc. | EMMA | Lim Seah H. Director | 0 | $0 | 240,000 (Direct) | View |